Study | Country Study period Study design |
Data source | Exposure definition | Non-exposure definition | Exposition period | Sample size (exposed/unexposed) Or (case / control) |
Remarks | Risk of bias |
---|---|---|---|---|---|---|---|---|
Ishibashi 2017 |
Japan 2000 - 2016 retrospective cohort |
15 Japanese institutions. | Pregnancies in long QT patients with Carteolol therapy. |
unexposed, sick
Pregnancies in long QT patients without β-blocker therapy. |
during pregnancy (anytime or not specified) | 2 / 94 | Exposure: 1 carteolol (15mg/day, 0.25mg/ kg/day) in the text but 2 in the Supplemental Table2. The considered number of exposure was 2 because it corresponds to the 'right' sum of exposure to beta-blockers. | |
All data were collected with checking their maternity record book. |
Study | Country Study period Study design |
Data source | Case | Control | Exposition | Exposition period | Sample size (exposed/unexposed) Or (case / control) |
Remarks | Risk of bias |
---|
Risk of bias: : NA; : low; : moderate; : serious; : critical; : unclear;